Your browser doesn't support javascript.
loading
Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4+ T Cells.
Liu, Haiyin; Wilson, Kayla R; Schriek, Patrick; Macri, Christophe; Blum, Annabelle B; Francis, Lauren; Heinlein, Melanie; Nataraja, Champa; Harris, James; Jones, Sarah A; Gray, Daniel H D; Villadangos, Jose A; Mintern, Justine D.
Afiliação
  • Liu H; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Wilson KR; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Schriek P; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Macri C; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Blum AB; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Francis L; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Heinlein M; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
  • Nataraja C; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3013, Australia.
  • Harris J; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Jones SA; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Gray DHD; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Villadangos JA; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
  • Mintern JD; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3013, Australia.
J Immunol ; 205(5): 1207-1216, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32747505
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Antígenos de Histocompatibilidade Classe II / Linfócitos T Reguladores / Ubiquitinação Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Antígenos de Histocompatibilidade Classe II / Linfócitos T Reguladores / Ubiquitinação Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália